Medical Image Center, Shenzhen Hospital, Southern Medical University, Shenzhen, China.
The Third of Clinical Medicine, Southern Medical University, Shenzhen, China.
Future Oncol. 2024;20(35):2747-2756. doi: 10.1080/14796694.2024.2396273. Epub 2024 Sep 13.
This study aims to investigate the efficacy of multifactorial MRI in diagnosing breast cancer, specifically in the context of predicting lymphovascular invasion (LVI). The patients were stratified into two groups: the primary group (100 patients) and the validation group (100 patients), based on essential characteristics. Multifactorial MRI, encompassing tumor size evaluation, diffusion coefficient assessment and dynamic contrast enhancement, was employed for patient examination. Statistically significant differences were observed in tumor size, diffusion coefficient and dynamic contrast enhancement between groups with LVI (LVI+) and those without (LVI-). Key parameters were identified for predicting the degree of invasion. The results affirm the effectiveness of multifactorial MRI in forecasting LVI.
本研究旨在探究多因素 MRI 在诊断乳腺癌方面的功效,特别是在预测淋巴血管侵犯(LVI)方面。患者根据基本特征分为两组:主要组(100 例)和验证组(100 例)。多因素 MRI 用于患者检查,包括肿瘤大小评估、扩散系数评估和动态对比增强。在有 LVI(LVI+)和没有 LVI(LVI-)的组之间,肿瘤大小、扩散系数和动态对比增强方面存在统计学显著差异。确定了预测侵犯程度的关键参数。结果证实了多因素 MRI 在预测 LVI 方面的有效性。